FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.4-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

1157143009: Loncastuximab tesirine (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
4579295017 Loncastuximab tesirine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4579296016 Loncastuximab tesirine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
4579295017 Loncastuximab tesirine en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
4579296016 Loncastuximab tesirine (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Loncastuximab tesirine Is a Monoclonal antibody true Inferred relationship Existential restriction modifier (core metadata concept)
Loncastuximab tesirine Is a Antineoplastic agent (substance) true Inferred relationship Existential restriction modifier (core metadata concept)

Inbound Relationships Type Active Source Characteristic Refinability Group
Loncastuximab tesirine-containing product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Loncastuximab tesirine Inferred relationship Existential restriction modifier (core metadata concept) 1
Loncastuximab tesirine only product The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Loncastuximab tesirine Inferred relationship Existential restriction modifier (core metadata concept) 1
Product containing loncastuximab tesirine in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Loncastuximab tesirine Inferred relationship Existential restriction modifier (core metadata concept) 1
Loncastuximab tesirine only product in parenteral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. True Loncastuximab tesirine Inferred relationship Existential restriction modifier (core metadata concept) 1

This concept is not in any reference sets

Back to Start